Cargando…
Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview
Pancreatic Ductal AdenoCarcinoma (PDAC) is one of the most lethal malignancies of all solid cancers. Precancerous lesions for PDAC include PanIN, IPMNs and MCNs. PDAC has a poor prognosis with a 5-year survival of approximately 6%. Whereas Periampulary AdenoCarcinoma (PAC) having four anatomic subty...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128383/ https://www.ncbi.nlm.nih.gov/pubmed/30258276 http://dx.doi.org/10.2174/1389202919666180221160753 |
_version_ | 1783353631512199168 |
---|---|
author | Sikdar, Nilabja Saha, Gourab Dutta, Ashmita Ghosh, Shibajyoti Shrikhande, Shailesh V. Banerjee, Sudeep |
author_facet | Sikdar, Nilabja Saha, Gourab Dutta, Ashmita Ghosh, Shibajyoti Shrikhande, Shailesh V. Banerjee, Sudeep |
author_sort | Sikdar, Nilabja |
collection | PubMed |
description | Pancreatic Ductal AdenoCarcinoma (PDAC) is one of the most lethal malignancies of all solid cancers. Precancerous lesions for PDAC include PanIN, IPMNs and MCNs. PDAC has a poor prognosis with a 5-year survival of approximately 6%. Whereas Periampulary AdenoCarcinoma (PAC) having four anatomic subtypes, pancreatic, Common Bile Duct (CBD), ampullary and duodenum shows relative better prognosis. The highest incidence of PDAC has been reported with black with respect to white population. Similarly, incidence rate of PAC also differs with different ethnic populations. Several lifestyle, environmental and occupational exposures including long-term diabetes, obesity, and smoking, have been linked to PDAC, however, for PAC the causal risk factors were poorly described. It is now clear that PDAC and PAC are a multi-stage process resulting from the accumulation of genomic alterations in the somatic DNA of normal cells as well as inherited mutations. Approximately 10% of PDAC have a familial inheritance. Germline mutations in CDKN2A, BRCA2, STK11, PALB2, PRSS1, etc., as well as certain syndromes have been well associated with predisposition to PDAC. KRAS, CDKN2A, TP53 and SMAD4 are the 4 “mountains” (high-frequency driver genes) which have been known to earliest somatic alterations for PDAC while relatively less frequent in PAC. Our understanding of the molecular carcinogenesis has improved in the last few years due to extensive research on PDAC which was not well explored in case of PAC. The genetic alterations that have been identified in PDAC and different subgroups of PAC are important implications for the development of genetic screening test, early diagnosis, and prognostic genetic markers. The present review will provide a brief overview of the incidence and prevalence of PDAC and PAC, mainly, increased risk in India, the several kinds of risk factors associated with the diseases as well as required genetic alterations for disease initiation and progression. |
format | Online Article Text |
id | pubmed-6128383 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Bentham Science Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-61283832019-03-01 Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview Sikdar, Nilabja Saha, Gourab Dutta, Ashmita Ghosh, Shibajyoti Shrikhande, Shailesh V. Banerjee, Sudeep Curr Genomics Article Pancreatic Ductal AdenoCarcinoma (PDAC) is one of the most lethal malignancies of all solid cancers. Precancerous lesions for PDAC include PanIN, IPMNs and MCNs. PDAC has a poor prognosis with a 5-year survival of approximately 6%. Whereas Periampulary AdenoCarcinoma (PAC) having four anatomic subtypes, pancreatic, Common Bile Duct (CBD), ampullary and duodenum shows relative better prognosis. The highest incidence of PDAC has been reported with black with respect to white population. Similarly, incidence rate of PAC also differs with different ethnic populations. Several lifestyle, environmental and occupational exposures including long-term diabetes, obesity, and smoking, have been linked to PDAC, however, for PAC the causal risk factors were poorly described. It is now clear that PDAC and PAC are a multi-stage process resulting from the accumulation of genomic alterations in the somatic DNA of normal cells as well as inherited mutations. Approximately 10% of PDAC have a familial inheritance. Germline mutations in CDKN2A, BRCA2, STK11, PALB2, PRSS1, etc., as well as certain syndromes have been well associated with predisposition to PDAC. KRAS, CDKN2A, TP53 and SMAD4 are the 4 “mountains” (high-frequency driver genes) which have been known to earliest somatic alterations for PDAC while relatively less frequent in PAC. Our understanding of the molecular carcinogenesis has improved in the last few years due to extensive research on PDAC which was not well explored in case of PAC. The genetic alterations that have been identified in PDAC and different subgroups of PAC are important implications for the development of genetic screening test, early diagnosis, and prognostic genetic markers. The present review will provide a brief overview of the incidence and prevalence of PDAC and PAC, mainly, increased risk in India, the several kinds of risk factors associated with the diseases as well as required genetic alterations for disease initiation and progression. Bentham Science Publishers 2018-09 2018-09 /pmc/articles/PMC6128383/ /pubmed/30258276 http://dx.doi.org/10.2174/1389202919666180221160753 Text en © 2018 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
spellingShingle | Article Sikdar, Nilabja Saha, Gourab Dutta, Ashmita Ghosh, Shibajyoti Shrikhande, Shailesh V. Banerjee, Sudeep Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview |
title | Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview |
title_full | Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview |
title_fullStr | Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview |
title_full_unstemmed | Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview |
title_short | Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview |
title_sort | genetic alterations of periampullary and pancreatic ductal adenocarcinoma: an overview |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128383/ https://www.ncbi.nlm.nih.gov/pubmed/30258276 http://dx.doi.org/10.2174/1389202919666180221160753 |
work_keys_str_mv | AT sikdarnilabja geneticalterationsofperiampullaryandpancreaticductaladenocarcinomaanoverview AT sahagourab geneticalterationsofperiampullaryandpancreaticductaladenocarcinomaanoverview AT duttaashmita geneticalterationsofperiampullaryandpancreaticductaladenocarcinomaanoverview AT ghoshshibajyoti geneticalterationsofperiampullaryandpancreaticductaladenocarcinomaanoverview AT shrikhandeshaileshv geneticalterationsofperiampullaryandpancreaticductaladenocarcinomaanoverview AT banerjeesudeep geneticalterationsofperiampullaryandpancreaticductaladenocarcinomaanoverview |